Pentoxifylline's Protective Role in Gastric Injury from Sepsis
Author Information
Author(s): Paredes Sergio D., Hernández-Cortés Jorge, Falahat Farzin, Rancan Lisa, Arias-Díaz Javier, Vara Elena
Primary Institution: Complutense University of Madrid
Hypothesis
Does pentoxifylline protect against gastric mucosal injury induced by sepsis?
Conclusion
Pentoxifylline effectively restores phosphatidylcholine production and reduces gastric mucosal injury caused by sepsis.
Supporting Evidence
- LPS administration decreased phosphatidylcholine synthesis in gastric mucosa.
- Pentoxifylline treatment blocked the negative effects of LPS on phosphatidylcholine production.
- Pentoxifylline reduced levels of inflammatory mediators associated with gastric injury.
- Significant increases in myeloperoxidase activity were observed after LPS treatment.
Takeaway
This study shows that a medicine called pentoxifylline can help protect the stomach from damage when sick with sepsis.
Methodology
Male Wistar rats were given LPS to induce sepsis and then treated with either saline or pentoxifylline, followed by analysis of gastric mucosa samples.
Potential Biases
Potential bias in the selection of treatment groups and the specific animal model used.
Limitations
The specific dose and timing of pentoxifylline administration may not reflect all clinically relevant regimens.
Participant Demographics
Male Wistar rats weighing between 250 and 300 g.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website